New Leadership at Mars Petcare
Mars has recently announced significant leadership changes within its Veterinary Health and Science & Diagnostics divisions, reflecting its commitment to advancing pet care services. Nefertiti Greene is stepping into the role of Global President for Mars Veterinary Health, while Katie Devine will take over as the new leader of the Science & Diagnostics division. These changes underscore Mars' commitment to excellence in pet health and technology, making it a proactive player in a growing market valued at over $30 billion.
Nefertiti Greene's Journey
Nefertiti Greene, who joined Mars in 2022, has played a vital role in the development of the Science & Diagnostics division. Over the past two years, Greene has facilitated substantial growth and built a robust portfolio in diagnostics. Her extensive background encompasses almost three decades in health services, including leadership roles at major companies such as Johnson & Johnson and Bayer, where she honed her skills in the pharmaceutical and medical technology sectors.
Insights from Leadership
Loïc Moutault, President of Mars Petcare, expressed his enthusiasm about Greene's transition, stating, "Nef will lead the Veterinary Health business, guiding 70,000 associates devoted to improving animal welfare. Her blend of experience and passion for veterinary services is a significant asset as we strive to deliver top-notch care for pets." Greene herself shared her excitement, emphasizing the significance of providing quality care through numerous veterinary visits facilitated by Mars' extensive network of hospitals worldwide.
Welcoming Katie Devine
Joining Mars from Johnson & Johnson, Katie Devine brings over 25 years of valuable experience in consumer health and pharmaceuticals. In her previous position, she managed a substantial business unit generating nearly $6.5 billion in revenue. Devine's background includes vital contributions across various health sectors, such as Cardiovascular and Allergy care, positioning her well to lead Mars Science & Diagnostics.
Devine's Vision for the Future
With an emphasis on innovation in veterinary diagnostics, Moutault welcomed Devine with optimism. He noted, "As pets cannot communicate their health needs verbally, enhanced diagnostics are crucial for veterinarians to understand and address these needs effectively. Katie is well-equipped to lead this vital initiative forward." Devine is equally eager, viewing Mars as a company she has long admired and expressing her enthusiasm for advancing animal health knowledge and transformative solutions.
The Mars Commitment to Pet Health
Mars operates under the belief that pets improve our world, which inspires their Petcare purpose: A BETTER WORLD FOR PETS. With a focus on promoting the health and happiness of pets, Mars remains dedicated to raising the standards in veterinary care, nutrition, and diagnostics. The company’s reputation as a leading global player in the pet care market, which has been built over nearly nine decades, is testament to its unwavering commitment to quality and innovation in the pet care sector.
About Mars, Incorporated
Mars, Incorporated is a thriving $50 billion family-owned enterprise known for its commitment to quality, responsibility, and mutuality. It produces a variety of beloved pet care brands such as ROYAL CANIN®, PEDIGREE®, and WHISKAS®. Alongside its vast international network of veterinary hospitals, including BANFIELD™ and BLUEPEARL™, Mars offers advanced diagnostics through ANTECH®, enhancing the quality of veterinary care provided to pets. The Mars Five Principles guide its 150,000 employees' daily actions to create a better world for people and pets alike.
Frequently Asked Questions
What leadership changes did Mars Petcare announce?
Mars Petcare announced Nefertiti Greene as the new Global President for Veterinary Health and Katie Devine for Science & Diagnostics.
What experience does Nefertiti Greene bring to her new role?
Nefertiti Greene has extensive experience in health services, with a career spanning almost three decades at leading companies.
Why is Katie Devine's leadership significant?
Katie Devine brings over 25 years of experience from Johnson & Johnson, with expertise in various health sectors and significant revenue management.
What is Mars' vision for pet health?
Mars aims to create a better world for pets, focusing on their health and well-being through innovative veterinary care and solutions.
How does Mars ensure the quality of its pet care products?
Mars is committed to high standards guided by its Five Principles, ensuring quality and responsibility in all its offerings.
